PHARMACOLOGICAL AGENTS USED IN POSTPARTUM HEMORRHAGE AND THEIR CLINICAL IMPORTANCE

Authors

  • Rustamova Moxlaroy Teacher of public health technical college named after Republic No. 1 Abu Ali Ibn Sina Author

Abstract

This paper examines the pharmacological agents used in the management of postpartum hemorrhage and their clinical significance in obstetric practice. Postpartum hemorrhage is a major cause of maternal morbidity and mortality worldwide and requires immediate medical intervention. The study describes the causes of postpartum hemorrhage, commonly summarized as the “4 Ts” (Tone, Trauma, Tissue, Thrombin), and focuses on pharmacological treatment options. It analyzes uterotonic drugs such as oxytocin, methylergometrine, prostaglandin analogues, and carbetocin, as well as antifibrinolytic agents like tranexamic acid. The mechanisms of action, indications, and importance of timely administration are highlighted. Special attention is given to the role of nurses in early recognition of bleeding, drug administration, patient monitoring, and emergency care. Understanding pharmacological management of postpartum hemorrhage is essential for improving maternal outcomes and reducing preventable maternal deaths.

References

1. Cunningham, F. G., Leveno, K. J., Bloom, S. L., et al. (2024). Williams Obstetrics (26th ed.). New York: McGraw-Hill Education.

2. FIGO (International Federation of Gynecology and Obstetrics). (2023). Postpartum Hemorrhage Prevention and Management Guidelines. London: FIGO.

3. World Health Organization (WHO). (2023). WHO Recommendations for the Prevention and Treatment of Postpartum Hemorrhage. Geneva: WHO.

4. World Health Organization (WHO). (2024). Managing Complications in Pregnancy and Childbirth. Geneva: WHO.

5. American College of Obstetricians and Gynecologists (ACOG). (2024). Practice Bulletin: Postpartum Hemorrhage. Washington, DC: ACOG.

6. Miller, S., et al. (2022). Tranexamic acid for postpartum hemorrhage: Clinical evidence and recommendations. The Lancet, 389(10084), 2105–2116.

7. Gülmezoglu, A. M., et al. (2023). Uterotonic drugs for preventing postpartum hemorrhage. Cochrane Database of Systematic Reviews.

8. James, D. K., et al. (2023). High Risk Pregnancy: Management Options (6th ed.). Elsevier.

9. Cunningham, F. G., et al. (2024). Hemorrhage in obstetrics: pathophysiology and management. Obstetrics & Gynecology Clinics.

10. Royal College of Obstetricians and Gynaecologists (RCOG). (2023). Prevention and Management of Postpartum Haemorrhage. London: RCOG.

Downloads

Published

2026-06-18